Actions
Pages
Subscribe for newsletter
Stories
The Canadian government has launched a C$1.5 billion Critical Minerals Infrastructure Fund (CMIF) dedicated to enhancing clean energy, electrification, transportation, and infrastructure projects. Its primary focus is to boost the supply chain of critical minerals vital for achieving a sustainable, net-zero emissions goal.
This initiative is part of Canada's C$3.8 billion critical minerals strategy, aimed at developing minerals such as copper, cobalt, and nickel, which are essential for batteries, wind turbines, and solar panels. Given the anticipated surge in global demand for these minerals in the shift towards low-carbon solutions, this sector is gaining increasing significance.
Canada Energy and Natural Resources Minister Jonathan Wilkinson said, "Through the C$1.5bn CMIF, Canada will make strategic investments in projects to help enable and grow the sustainable development of these minerals, reinforcing Canada’s position as a global supplier of choice for clean technology, clean energy, and the resources the world needs to build a prosperous net-zero economy.
The program's initial phase focuses on pre-construction and infrastructure deployment. Future implications include bolstering Canada's clean energy and electrification initiatives, potentially transforming the country into a global clean technology hub.
The CMIF strategically positions Canada in a global race for clean technology leadership, challenging existing geopolitical dependencies on critical minerals, especially from countries like China.
Story
Gulfstream completed their world-first trans-Atlantic flight powered by 100% Sustainable Aviation Fuel (SAF). SAF consists entirely of Hydroprocessed Esters and Fatty Acids (pure HEFA), derived from refinement of renewable inputs like oils and fats. SAF boasts a minimum of 70% lower lifecycle CO2 emissions compared to fossil-based jet fuel.
Achieving environmental sustainability for the aviation industry is now tangible. SAF could become commercially viable and propel more climate friendly advancements in the future.
“Gulfstream is innovating for a sustainable future,” said Mark Burns, President of Gulfstream. “One of the keys to reaching business aviation’s long-term decarbonization goals is the broad use of SAF in place of fossil-based jet fuel. The completion of this world-class flight helps to advance business aviation’s overarching sustainability mission and create positive environmental impacts for future generations.”
The success of Gulfstream's flight is expected to boost more exploration into SAF's capabilities and compatibility, influencing both regulatory frameworks and market dynamics towards more sustainable aviation practices.
SAF has limited current market supply and prices are considerably higher than conventional fossil-based fuels. Presently, SAF constitutes less than 0.1% of jet fuel volumes, and existing fuel standards permit only a 50% SAF blend in commercial jet engines.
Story
Hong Kong's Insilico Medicine teams up with New Zealand's SRW Laboratories to develop AI-driven longevity nutraceuticals, leveraging Insilico's Pharma.AI platform to expedite the discovery of natural compounds that extend healthspan.
Aging populations are on the rise, set to reach 2.1 billion by 2050, with a threefold increase in those aged 80 or older. Insilico and SRW's collaboration uses AI tech to address age-related health issues with a focus on natural wellness to sustain a longer, better quality of life.
“We’ve been utilising our technology to increase output in the pharmaceutical space for years, but this is the first time we’re turning our attention to the natural supplement sector. We’re excited to help SRW make huge strides in analysing which compounds are the most effective and bring them to market. Extending the number of healthy years in a person’s life is a very motivating mission,” said Alex Zhavoronkov, PhD, co-CEO and founder of Insilico.
The partnership anticipates unveiling its first AI-assisted product suite in 2024.
By merging biotech, AI and natural sciences together, this method aims to target cellular aging rather than treating symptoms. The integration of AI into nutraceuticals reflects a holistic health approach.
While the promise of AI in drug discovery is immense, there remains a cautious outlook due to previous setbacks in AI-generated drugs, highlighting the need for successful clinical outcomes to fully validate this approach.
Story
Innovators
Scroll
Open
Close